SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13E4 - Issuer tender offer statement.:
SEC Accession No. 0000950135-96-004125
Filing Date
1996-09-27
Accepted
1996-09-27 00:00:00
Documents
5
Group Members
GENZYME CORPNEOZYME II ACQUISITION CORP.
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 GENZYME CORPORATION SC 13E4 24029
2 OFFER TO PURCHASE EX-99.A1 353622
3 PURCHASE AGREEMENT EX-99.C1 95072
4 AUDITED FINANCIAL STATEMENTS EX-99.G1 398854
5 PROFORMA FINANCIAL STATEMENTS EX-99.G2 105908
  Complete submission text file 0000950135-96-004125.txt   979924
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Filed by) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Subject) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13E4 | Act: 34 | File No.: 005-37205 | Film No.: 96635853
SIC: 2836 Biological Products, (No Diagnostic Substances)